On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more
On 2 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the eighth episode of its Life Science Lectures webinar series. The focus of the webinar, titled: ‘‘Implementing the European Health Data Space’’ was to delve into the implications of the secondary use of… read more
Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more
EUCOPE congratulates Ursula von der Leyen on the confirmation of her second term as President of the European Commission. Her leadership and commitment to public health have been instrumental in steering Europe through challenging times. It is now fundamental to build on these accomplishments, delivering… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 7 new members at its quarterly Members Meeting on 18 June 2024, following Board approval. The new members joining the EUCOPE network are Acadia, Edelman Global Advisory, Elevate Bio, GE Healthcare, Regeneron, Rhythm Pharmaceuticals and… read more
At the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) meeting on 21 June, Health Ministers adopted Council Conclusions on the Future of the European Health Union. Presenting the Council’s perspective on the forthcoming EU health agenda, the Conclusions outline strategic priorities and actions… read more
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) extends its heartfelt congratulations to the newly elected Members of the European Parliament (MEPs). As the key representative body for predominantly small and medium-sized innovative pharmaceutical companies in Europe, EUCOPE recognises the pivotal role MEPs play in shaping… read more
The Regulation on Substances of Human Origin (SoHO) has been officially adopted by the EU Institutions, following the European Parliament’s approval on 24 April and the formal adoption by the Council of the European Union on 27 May. The new Regulation aims to improve the… read more
In June 2024, the Cancer Patients Europe, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Society of Pathology and Lung Cancer Europe (LuCE) published a joint statement on increasing access to genomic testing, delivering on the ambitions of Europe’s Beating Cancer Plan. Over the past 10 years,… read more
On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View